2008•Ningxia Medical JournalRequires access

The clinical effects of Ulinastatin in patients with severe sepsis

Zhang Yaobin

Open publisher page 0 citations

Abstract

Objective To investigate the efficacy of Ulinastatin(UTI)in patients with severe sepsis syndrome.Methods 42 patients with severe sepsis syndrome were randomly divided into UTI group(n=22)and control group(n=20).In the group of UTI,patients had Ulinastatin 600000 IU two times every day for 10 days.The same treatment was given to two groups.Temperature,respiration,heart rate and white blood cell,neutrocyte percent and other plasma biochemistry indexes were determined before the treatment and after the treatment.Results After the treatment,the levels of temperature,respiration,heart rate and white blood cell,neutrocyte percent were significantly decreased in UTI group(P0.05);plasma alanine amino transferase,aspartate amino transferase,blood urea nitrogen,lactate dehydrogenase and MB isoenzyme of creatine kinase were decreased in two groups after the treatment(P0.05),but the decreases of all these plasma biochemistria indexes were more marked in UTI group(P0.05).Conclusion UTI has beneficial effects in patients with severe sepsis syndrome.

About this research paper

What this paper is about

Objective To investigate the efficacy of Ulinastatin(UTI)in patients with severe sepsis syndrome.Methods 42 patients with severe sepsis syndrome were randomly divided into UTI group(n=22)and control group(n=20).In the group of UTI,patients had Ulinastatin 600000 IU two times every day for 10 days.The same treatment was given to two groups.Temperature,respiration,heart rate and white blood cell,neutrocyte percent and other plasma biochemistry indexes were determined before the treatment and after the treatment.Results After the treatment,the levels of temperature,respiration,heart rate and white blood cell,neutrocyte percent were significantly decreased in UTI group(P0.05);plasma alanine amino transferase,aspartate amino transferase,blood urea nitrogen,lactate dehydrogenase and MB isoenzyme of creatine kinase were decreased in two groups after the treatment(P0.05),but the decreases of all these plasma biochemistria indexes were more marked in UTI group(P0.05).Conclusion UTI has beneficial effects in patients with severe sepsis syndrome.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the efficacy of Ulinastatin(UTI)in patients with severe sepsis syndrome.Methods 42 patients with severe sepsis syndrome were randomly divided into UTI group(n=22)and control group(n=20).In the group of UTI,patients had Ulinastatin 600000 IU two times every day for 10 days.The same treatment was given to two groups.Temperature,respiration,heart rate and white blood cell,neutrocyte percent and other plasma biochemistry indexes were determined before the treatment and after the treatment.Results After the treatment,the levels of temperature,respiration,heart rate and white blood cell,neutrocyte percent were significantly decreased in UTI group(P0.05);plasma alanine amino transferase,aspartate amino transferase,blood urea nitrogen,lactate dehydrogenase and MB isoenzyme of creatine kinase were decreased in two groups after the treatment(P0.05),but the decreases of all these plasma biochemistria indexes were more marked in UTI group(P0.05).Conclusion UTI has beneficial effects in patients with severe sepsis syndrome.

Key concepts: Ulinastatin, Medicine, White blood cell, Sepsis, Creatine kinase, Lactate dehydrogenase, Internal medicine, Gastroenterology

Related papers

Back to paper searchBrowse research topicsOriginal source
The clinical effects of Ulinastatin in patients with severe sepsis — Research Paper | ScholarLens